Sangamo Therapeutics (LTS:0R1D) Other Long-Term Liabilities : $1.21 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sangamo Therapeutics Other Long-Term Liabilities?

Sangamo Therapeutics's other long-term liabilities for the quarter that ended in Mar. 2024 was $1.21 Mil.

Sangamo Therapeutics's quarterly other long-term liabilities declined from Sep. 2023 ($1.32 Mil) to Dec. 2023 ($1.19 Mil) but then increased from Dec. 2023 ($1.19 Mil) to Mar. 2024 ($1.21 Mil).

Sangamo Therapeutics's annual other long-term liabilities declined from Dec. 2021 ($1.22 Mil) to Dec. 2022 ($1.21 Mil) and declined from Dec. 2022 ($1.21 Mil) to Dec. 2023 ($1.19 Mil).

Sangamo Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for Sangamo Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangamo Therapeutics Other Long-Term Liabilities Chart

Sangamo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Sangamo Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Sangamo Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Sangamo Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sangamo Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangamo Therapeutics (LTS:0R1D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SGMO:USA GBY:Germany

Address

7000 Marina Boulevard, Brisbane, CA, USA, 94005

Website

https://www.sangamo.com

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Sangamo Therapeutics (LTS:0R1D) Headlines

No Headlines